ALISON SWELBAR: Open Payments
NPI 1487350286 · MONTGOMERY, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$714 in 29 payments from 10 companies in 2025. Trend: 2023 $122 · 2024 $0 · 2025 $714
Food & beverage: $714
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $195 |
| QOL Medical, LLC | 6 | $160 |
| Novo Nordisk Inc | 3 | $136 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $64 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $51 |
| Madrigal Pharmaceuticals | 1 | $36 |
| PFIZER INC. | 1 | $23 |
| TerSera Therapeutics LLC | 1 | $20 |
| Olympus America Inc. | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 4 | $14 |
Products named: RINVOQ, Sucraid, Wegovy, XIFAXAN, ENTYVIO, REZDIFFRA, VELSIPITY, SKYRIZI.
Industry payments across OH — which companies pay providers there.
